Bank Of New York Mellon Corp Chemo Centryx, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $651,820 - $1.52 Million	29,401 Added 12.34%	267,627 $13.8 Million
Q2 2022 Aug 15, 2022	SELL	$15.36 - $27.51 $747,571 - $1.34 Million	-48,670 Reduced 16.96%	238,226 $5.9 Million
Q1 2022 May 11, 2022	SELL	$22.22 - $39.12 $197,802 - $348,246	-8,902 Reduced 3.01%	286,896 $7.19 Million
Q4 2021 Feb 11, 2022	SELL	$18.38 - $40.5 $4,392 - $9,679	-239 Reduced 0.08%	295,798 $10.8 Million
Q3 2021 Nov 12, 2021	BUY	$13.18 - $19.83 $186,431 - $280,495	14,145 Added 5.02%	296,037 $5.06 Million
Q2 2021 Aug 11, 2021	BUY	$9.59 - $50.88 $675,183 - $3.58 Million	70,405 Added 33.29%	281,892 $3.77 Million
Q1 2021 May 13, 2021	SELL	$49.53 - $68.4 $345,768 - $477,500	-6,981 Reduced 3.2%	211,487 $10.8 Million
Q4 2020 Feb 09, 2021	SELL	$47.25 - $65.16 $188,338 - $259,727	-3,986 Reduced 1.79%	218,468 $13.5 Million
Q3 2020 Nov 12, 2020	BUY	$46.35 - $61.69 $495,157 - $659,034	10,683 Added 5.04%	222,454 $12.2 Million
Q2 2020 Aug 12, 2020	BUY	$38.58 - $65.07 $411,957 - $694,817	10,678 Added 5.31%	211,771 $12.2 Million
Q1 2020 May 06, 2020	SELL	$32.73 - $50.78 $210,519 - $326,616	-6,432 Reduced 3.1%	201,093 $8.08 Million
Q4 2019 Feb 14, 2020	BUY	$6.81 - $39.55 $193,329 - $1.12 Million	28,389 Added 15.85%	207,525 $8.21 Million
Q3 2019 Nov 07, 2019	BUY	$6.47 - $8.96 $27,342 - $37,864	4,226 Added 2.42%	179,136 $1.21 Million
Q2 2019 Aug 12, 2019	BUY	$8.31 - $14.85 $343,128 - $613,171	41,291 Added 30.9%	174,910 $1.63 Million
Q1 2019 May 14, 2019	SELL	$10.01 - $13.89 $61,921 - $85,923	-6,186 Reduced 4.42%	133,619 $1.86 Million
Q4 2018 Feb 11, 2019	BUY	$9.15 - $12.26 $118,556 - $158,852	12,957 Added 10.21%	139,805 $1.53 Million
Q3 2018 Nov 09, 2018	BUY	$10.49 - $13.72 $84,654 - $110,720	8,070 Added 6.79%	126,848 $0
Q2 2018 Aug 06, 2018	BUY	$10.62 - $13.98 $129,117 - $169,968	12,158 Added 11.4%	118,778 $1.57 Million
Q1 2018 May 15, 2018	SELL	$5.9 - $14.99 $25,169 - $63,947	-4,266 Reduced 3.85%	106,620 $1.45 Million
Q4 2017 Feb 09, 2018	BUY	$5.53 - $8.42 $613,199 - $933,660	110,886	110,886 $660,000

Others Institutions Holding CCXI

# of Institutions

Shares Held

66.3K

Call Options Held

Put Options Held

View Full List

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account